This COP1-mediated suppression of ACSL4 protein levels significantly inhibits lipid peroxidation—a hallmark of ferroptosis—thereby conferring ferroptosis resistance to RCC cells. The gene discussed is ACSL4; the disease is renal cell carcinoma.